Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Products & comparisons
Product source

Codeage Liposomal Nicotinamide Riboside+ Capsule: DSLD Label Record 333430

A DSLD label record for Codeage Liposomal Nicotinamide Riboside+ capsules lists nicotinamide riboside, betaine anhydrous and trans-pterostilbene with amounts per labelled serving. The record documents label declarations only, not efficacy, safety or approval. [1]

Automatic summary · not editorially reviewed

Label · NIH DSLD
Liposomal Nicotinamide Riboside+Original label · NIH DSLD
Liposomal Nicotinamide Riboside+

FROM THE ORIGINAL LABEL

A closer look at the product

Pack contents
60 Capsule(s)
Label serving
1 Capsule(s)
Servings per container
60
Barcode / SKU
8 50049 60921 0
Open original label (PDF)
Ingredients & declared amounts3

Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.

IngredientAmountPer label serving
Nicotinamide Riboside500 mg1 Capsule(s)
Betaine Anhydrous102.5 mg1 Capsule(s)
trans-Pterostilbene100 mg1 Capsule(s)

Other ingredients: Methylcellulose, Sunflower Oil

Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.

The key findings

  1. DSLD record 333430 describes Codeage Liposomal Nicotinamide Riboside+ capsules. [1]

  2. The label declares nicotinamide riboside 500 mg, betaine anhydrous 102.5 mg and trans-pterostilbene 100 mg per labelled serving. [1]

  3. DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or retail availability. [1]

The source at a glance

Brand
Codeage
Form
Capsule
Pack contents
60 Capsule(s)
Label serving
1 Capsule(s)
Ingredients listed
Nicotinamide Riboside · Betaine Anhydrous · trans-Pterostilbene
Record type / format
Product label/database record (DSLD entry 333430); not a study.
Scope / context
The described product: Codeage Liposomal Nicotinamide Riboside+ capsules, as declared on the label record.
Summary based on
Product label / database record

Codeage capsule record in the NIH DSLD

This is a record in the NIH Office of Dietary Supplements Dietary Supplement Label Database (DSLD), entry 333430. The label names the product Liposomal Nicotinamide Riboside+, the brand as declared is Codeage, and the physical form is capsule. DSLD places it in the product category "Other Combinations." The label entered the database on 2025-08-22; the source notes this is not a product launch date. The record is a snapshot of label declarations.

Supporting source [1]

Declared ingredients and amounts per labelled serving

The record lists three declared ingredients with amounts per labelled serving: nicotinamide riboside 500 mg, betaine anhydrous 102.5 mg and trans-pterostilbene 100 mg. These are label facts as entered in the database. The source states the amounts are not personal dosing advice. The record does not describe how the ingredients are combined or what the serving consists of beyond the capsule form.

Supporting source [1]

What this DSLD listing does not establish

The source states that DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. No independent product testing, price or batch certificate is supplied by this record. The brand name alone does not show any effect on aging biology. The record therefore documents what the label declares, not what the product does.

Supporting source [1]

How to interpret this

Product label record; not evidence of efficacy or approval. Abstract-level record only: no independent testing, price, batch certificate or full label image was reviewed. Amounts are label facts, not dosing advice.

Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.

Source & supporting passages

[1]
Liposomal Nicotinamide Riboside+

Codeage · dsld.od.nih.gov

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    Product label name: Liposomal Nicotinamide Riboside+
  2. Finding 2 ↑

    Nicotinamide Riboside: 500 mg per labelled serving
  3. Finding 3 ↑

    DSLD inclusion does not establish efficacy, safety,

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…